Healthcare Pricing Policy
Ben discusses the potential negative impact of government pricing policies on medical innovation, highlighting how price controls could deter investment in drug development. The chapter delves into the specifics of Medicare's negotiation process with drug companies and the implications of potential price cram-downs, shedding light on the complexities of pharmaceutical pricing and innovation in the healthcare sector.In this clip
From this podcast
The Ben Shapiro Show
There’s No Such Thing As Free Medicine
Related Questions